Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 4 Cost-effectiveness of systematic CRT-D optimization versus optimal pharmacological therapy (OPT) from the perspective of the healthcare payer

From: Exploratory cost-effectiveness analysis of cardiac resynchronization therapy with systematic device optimization vs. standard (non-systematic) optimization: a multinational economic evaluation

 

ICER at 5 yearsa

ICER at 5 yearsa

Difference

 

Systematic CRT-D optimization vs. OPT

Standard CRT-D optimization vs. OPT

Systematic vs. Standard

Country

   

Germany

€ 16,359

€ 22,327

-27 %

France

€ 16,052

€ 23,019

-30 %

Spain

€ 24,440

€ 34,936

-30 %

Italy

€ 15,077

€ 20,738

-27 %

UK

£ 14,950

£ 20,861

-28 %

  1. aICERs are expressed as cost per QALY gained